setting
threshold
industrial
application
diverges
europe
robert
fitt
edward
nodder*
lack
rarely
used
ground
seeking
invalidate
patent
part
conventionally
viewed
relatively
low
meet
since
potential
invention
usually
readily
apparent
however
position
respect
biotechnology
often
le
clear-cut
biological
function
newly
identiﬁed
gene
protein
may
known
degree
certainty
european
ofﬁce
grappled
issue
many
year
forefront
examining
criterion
patentability
national
court
experience
area
faced
subject
litigation
eli
lilly
company
human
genome
science
inc
recently
decided
appeal
well
approach
assessing
ﬁeld
judgment
notable
analysis
interplay
relationship
interest
fragment
hunting
early
ﬁrst
detected
activity
sequenced
order
determine
sequence
nucleic
acid
encoded
could
probe
clone
actual
library
cloned
express
suitable
host
cell
involved
traditional
laboratory
work
required
signiﬁcant
investment
research
time
wet
advent
bioinformatics
beginning
opened
new
identifying
partly
result
project
vast
public
private
database
data
built
mined
using
computer
algorithm
trawl
displayed
similarity
key
must
reasonably
plausible
skilled
art
important
cooperate
stage
procedure
possible
opposition
proceeding
speeded
commercially
case
although
settled
law
principle
clearly
laid
technical
board
followed
free
apply
evaluation
fact
rather
give
deference
assessment
homology
previously
characterized
statistical
obtained
screening
process
enabled
researcher
identify
likely
distinction
lab
predicted
based
member
family
prove
assayed
crucial
present
much
needed
said
proposed
reliable
proposal
technique
encoding
established
neutrokine-a
ligand
superfamily
path
numerous
bristows
email
civ
author
published
oxford
university
press
right
reserved
nodder
including
leading
biotech
corporation
one
focused
tumour
necrosis
factor
founding
isolated
cytokine
act
inter-cellular
mediator
inﬂammation
immune
response
originally
shown
provoke
death
hence
name
subsequently
found
play
role
particular
rheumatoid
arthritis
least
eight
display
overlapping
also
individual
relation
wide
variety
type
system
today
therapeutic
monoclonal
antibody
remicade
humira
treat
immunological
disease
crohn
psoriasis
successfully
named
shortly
afterwards
ﬁled
disclosing
full-length
nucleotide
amino
included
claim
diagnostic
described
membership
include
conventional
precisely
neutrokine-as
subsequent
suggested
particularly
development
speciﬁc
lymphocyte
mature
plasma
produce
body
main
mechanism
targeting
foreign
particle
destruction
consequently
renamed
stimulator
showing
elevated
level
patient
suffering
lupus
supported
called
belimumab
number
searching
pat
late
independently
sometime
developed
following
grant
august
commenced
revocation
high
lillys
attack
validity
applicability
allegation
obviousness
insufﬁciency
common
thread
view
ﬁling
know
sure
trial
instance
kitchin
held
invalid
accepting
novel
ruled
simply
necessarily
sufﬁcient
confer
utility
upon
neither
general
knowledge
condition
diagnose
concluding
best
matter
expectation
far
generality
constitute
sound
concrete
basis
anything
except
later
publication
demonstrated
useful
treating
associated
disorder
change
claimed
susceptible
insufﬁcient
obvious
would
programme
candidate
pharmaceutical
composition
comprising
failed
altogether
depending
route
taken
two
prior
cited
still
lacked
inventive
step
provided
speculation
might
teach
person
solve
problem
handed
revoked
division
constituted
arbitrary
without
appealed
decision
coordination
hearing
arranged
take
place
lead-up
party
document
evidence
submitted
english
oral
amended
set
rejected
argument
noted
conﬁrmed
plausibility
teaching
recognize
practical
exploitation
industry
importance
lord
justice
jacob
gave
asserted
cooperation
happen
example
removed
need
saving
money
separate
fast
track
ﬁnal
reached
rapidly
thus
reducing
amount
damaging
commercial
uncertainty
caused
drag
took
opportunity
explain
difference
nature
england
wale
former
disclose
internal
relevant
dispute
factual
expert
witness
subjected
detailed
crossexamination
crucially
permissible
exceptional
introduce
considerable
ﬁndings
interfere
lower
directive
unless
error
upshot
bring
re-hearing
observed
different
administrative
closely
related
permit
admission
material
considered
furthermore
cross-examination
compulsory
disclosure
either
something
coarse
ﬁlter
inevitable
given
pressure
enormous
caseload
consider
profoundly
consequence
unusual
differ
came
applying
legal
question
immense
meaning
conducted
allowed
convention
granted
ﬁelds
technology
involve
deﬁned
follows
shall
made
kind
agriculture
interpret
stated
necessary
look
alter
free-standing
international
treaty
whose
signatory
state
provide
assistance
interpreting
various
formation
simple
discovery
partial
cannot
patentable
element
otherwise
produced
mean
even
structure
identical
natural
disclosed
recital
helped
put
context
whereas
mere
indication
contain
information
therefore
comply
specify
performs
interpretation
provision
patented
decide
whether
speciﬁcation
enough
particularization
amounted
depend
commented
consistent
concerning
purport
lay
reviewing
authority
concluded
discovering
able
show
concerned
bar
formulated
series
prop
ositions
adopted
box
applied
standard
compared
unduly
inﬂuenced
conclude
unconvinced
incredible
real
reason
supposing
true
good
say
probably
use
statement
left
ﬁnd
credible
reader
structurally
similar
believed
effect
make
answer
depended
sense
carry
us
argued
poorly
understood
regarded
purely
speculative
countered
within
read
regulation
inﬂammatory
treatment
diagnosis
autoimmune
reading
support
ten
notion
construed
broadly
includes
manufacturing
extracting
processing
enterprise
carried
continuously
gain
proﬁt
chiron
product
cure
rare
orphan
capable
intended
trade
capability
derivable
description
beneﬁt
genentech
way
exploiting
salk
institute
re-formulated
enquiry
recognizing
contribution
lead
nevertheless
remains
deﬁnite
term
purpose
moreover
prospect
directly
already
background
bayer
conversely
requirement
satisﬁed
merely
interesting
yield
yet
objective
achievable
carrying
similarly
exploit
granting
reserve
unexplored
applicant
patentee
unjustiﬁed
control
others
actively
investigating
eventually
actually
substance
essential
health
identiﬁcation
immediately
suggest
hand
incompletely
attributable
excess
deﬁciency
though
scientiﬁc
achievement
merit
finally
study
bearing
understand
follow
envisage
told
determined
asked
thought
pure
accept
submission
trying
inevitably
stringent
ﬁnding
onset
immediate
event
working
conclusion
bound
go
afﬁrms
judge
entitled
reach
pain
divergence
operation
always
occasion
intrinsic
inherently
valid
throughout
challenged
higher
appears
doubtful
opposite
unclear
owner